Using Bone Turnover Markers to Predict Changes in BMD After Alendronate Therapy in Postmenopausal Women

被引：0
|
作者：
Mcnabb, Brian [1 ]
Vittinghoff, Eric [2 ]
Schwartz, Ann [2 ]
Bauer, Douglas [2 ]
Ensrud, Kristine [3 ,4 ]
Barrett-Connor, Elizabeth [5 ]
Eastell, Richard [6 ]
Black, Dennis [2 ]
机构：
[1] Univ Calif San Francisco, San Francisco VA Med Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Minnesota, Minneapolis, MN 55455 USA
[4] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA
[5] Univ Calif San Diego, San Diego, CA 92103 USA
[6] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU0283
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [21] Effects of Denosumab vs Alendronate on Bone Mineral Density (BMD), Bone Turnover Markers (BTM), and Safety in Women Previously Treated with Alendronate.
    Kendler, D. L.
    Benhamou, C. L.
    Brown, J. P.
    Lillestol, M.
    Roux, C.
    Man, H. S.
    Siddhanti, S.
    Martin, J. San
    Bone, H. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S473 - S473
  • [22] Predictive value of biochemical markers of bone turnover in the treatment of Japanese postmenopausal women with alendronate.
    Kurasawa, K
    Chaki, O
    Mochizuki, K
    Arata, Y
    Yoshikata, H
    Kikuchi, R
    Gorai, I
    Hirahara, F
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S446 - S446
  • [23] CHANGE IN BONE MINERAL DENSITY (BMD) OR BONE TURNOVER MARKERS (BTM) DID NOT PREDICT RISK OF VERTEBRAL FRACTURE AFTER DISCONTINUATION OF ALENDRONATE IN THE FLEX STUDY
    Chang, S.
    Bauer, D.
    Black, D.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S377 - S377
  • [24] Lasofoxifene increased BMD of the spine and hip and decreased bone turnover markers in postmenopausal women with low or normal BMD.
    McClung, M
    Siris, E
    Cummings, S
    Bone, H
    Recker, R
    Delmas, P
    Zanchetta, J
    Lewiecki, M
    Zerbini, C
    Miller, S
    Wolter, K
    Proulx, J
    Brunell, R
    Radecki, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S97 - S97
  • [25] Markers of bone turnover in postmenopausal women receiving hormone replacement therapy
    Hamwi, A
    Ganem, AH
    Grebe, C
    Kerschan-Schindl, K
    Preisinger, E
    Boschitsch, E
    Bieglmayer, C
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (05) : 414 - 417
  • [26] Changes in bone turnover markers after one year of alendronate treatment in osteoporosis
    Roman, JA
    Fernández, C
    Millán, J
    Fuertes, A
    Abad, L
    Pons, J
    Blasco, M
    Calvo, I
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [27] Bone Turnover Markers in Old and Postmenopausal Women
    Chan, Kien
    Nair, Preeti
    Pang, Wee Yang
    Chauhan, Anupam
    Inderjeeth, Charles
    Lim, Ee Mun
    AUSTRALASIAN JOURNAL ON AGEING, 2014, 33 : 46 - 47
  • [28] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude Laurent
    Brown, Jacques P.
    Lillestol, Michael
    Siddhanti, Suresh
    Man, Hoi-Shen
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 72 - 81
  • [29] Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life
    Panico, Annalisa
    Lupoli, Gelsy Arianna
    Marciello, Francesca
    Lupoli, Roberta
    Cacciapuoti, Marianna
    Martinelli, Addolorata
    Granieri, Luciana
    Iacono, Daniela
    Lupoli, Giovanni
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : CR442 - CR448
  • [30] Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
    Sarkar, S
    Reginster, JY
    Crans, GG
    Diez-Perez, A
    Pinette, KV
    Delmas, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) : 394 - 401
12345